Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05OQF
|
|||
Former ID |
DNC009891
|
|||
Drug Name |
N-(3,5-dichlorophenyl)-2-nitrobenzamide
|
|||
Synonyms |
N-(3,5-dichlorophenyl)-2-nitrobenzamide; CHEMBL564612; AC1LEFLS; AC1Q1WV0; Oprea1_875451; Oprea1_856946; ZINC103151; BDBM50297529; AKOS002518902; MCULE-6306742768; ST011167; KB-101427
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H8Cl2N2O3
|
|||
Canonical SMILES |
C1=CC=C(C(=C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)[N+](=O)[O-]
|
|||
InChI |
1S/C13H8Cl2N2O3/c14-8-5-9(15)7-10(6-8)16-13(18)11-3-1-2-4-12(11)17(19)20/h1-7H,(H,16,18)
|
|||
InChIKey |
RHMRIXDZQJDDKE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 316142-28-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bacterial Fatty acid synthetase I (Bact inhA) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.